nach oben

Heart Failure Reviews

Erschienen in:

01.11.2011

Arrhythmic complication in cardiorenal syndrome

verfasst von: Luigi Padeletti, Lisa Innocenti, Alessandro Paoletti Perini, Edoardo Gronda

Erschienen in: Heart Failure Reviews | Ausgabe 6/2011

Einloggen, um Zugang zu erhalten

Abstract

In this paper, two different aspects of the relationship between chronic kidney disease and sudden cardiac death (SCD) have been reviewed. In end-stage renal disease patients, SCD risk is increased, and among patients implanted with a cardioverter defibrillator (ICD), dialysed ones carry a superior relative risk compared to non-dialysed ones. Cardiorenal syndrome patients have increase in SCD risk, and when receiving ICD implantation, survival improves.

USRDS (2007) Annual data report Bethesda, Maryland: National institute of diabetes and digestive and kidney disease, 2007

Cheung AK, Sarnak MJ, Yan G et al (2004) Cardiac diseases in maintenance haemodialysis patients: results of the HEMO study. Kidney Int 65:2380–2389PubMedCrossRef

Wanner C, Krane V, Marz W et al (2005) Atorvastatin in patients with type 2 diabetes mellitus undergoing haemodialysis. N Engl J Med 353:238–248PubMedCrossRef

Myerburg RJ, Castellanos A (2006) Emerging paradigms of the epidemiology and demographics of sudden cardiac arrest. Heart Rhythm 3:235–239PubMedCrossRef

Ramirez G, Brueggemeyer CD, Newton JL (1984) Cardiac arrhythmias in haemodialysis in chronic renal failure patients. Nephron 36:212–218PubMedCrossRef

Gruppo emodialisi patologie cardiovascolari (1988) Multicentre cross sectional study of ventricular arrhythmias in chronically haemodialysed patients. Lancet 2:305–308

Mangrum JM, Lin D, Dimarco JP (2006) Prognostic value of LV systolic function in haemodialysis patients. Heart Rhythm 3:s154CrossRef

London GM (2003) Cardiovascular disease in chronic renal failure: pathophysiologic aspects. Semin Dial 16(2):85–94PubMedCrossRef

Munger MA, Ateshkadi A, Cheung AK et al (2000) Cardiopulmonary events during haemodialysis: effects of dialysis membranes and dialysate buffers. Am J Kidney Dis 36:130–139PubMedCrossRef

10.

Groos ML, Ritz E (2008) Hyperthrophy and fibrosis in the cardiomyopathy of uraemia: beyond coronary heart disease. Semin Dial 21(4):308–318CrossRef

11.

LeWinter MM, Decena B, Tischler MD et al (2000) Abnormalities of myocardial relaxation and filling: diastolic dysfunction. In: Hosenpud JD, Greenberg BH (eds) Congestive heart failure, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 94–98

12.

Keung EC (1989) Calcium current is increased in isolated adult myocytes from hypertrophied rat myocardium. Circ. Res 64:753–763

13.

Zaza A (2009) Serum potassium and arrhythmias. Europace 11:421–422PubMedCrossRef

14.

Karnik JA, Young BS, Lew NL et al (2001) Cardiac arrest and sudden death in dialysis units. Kidney Int 60:350–357PubMedCrossRef

15.

Bleyer AJ, Hartman J, Brannon PC et al (2006) Characteristic of sudden death in haemodialysis patients. Kidney Int 69:2268–2273PubMedCrossRef

16.

Schwartz PJ, Priori SG, Napolitano C (2000) The long QT syndrome. In: Zipes DP, Jalife J (eds) Cardiac electrophysiology. From cell to bedside, 3rd edn. WB Sauders Company, Philadelphia, PA, pp 597–615

17.

Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883PubMedCrossRef

18.

Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 252:225–237CrossRef

19.

Herzog CA, Li S, Weinhandl ED et al (2005) Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int 68:818–825PubMedCrossRef

20.

Sakhuja R, Keebler M, Lai TS et al (2009) Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol 103:735–741PubMedCrossRef

21.

Ronco C, Happio M, House A et al (2008) Cardiorenal sindrome. J Am Coll Cardiol 52:1527–1539PubMedCrossRef

22.

Jessupp M, Costanzo MR (2009) The cardiorenal syndrome. J Am Coll Cardiol 53(7):582–598CrossRef

23.

Go AS, Chertow GM, Fan Dongjie MPH et al (2004) Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med 351:1296–1305PubMedCrossRef

24.

Iguchi Y, Kimura K, Kobayashi K et al (2008) Relation of atrial fibrillation to glomerular filtration rate. Am J Cardiol 102:1056–1059PubMedCrossRef

25.

Watanabe H, Watanabe T, Sasaki S et al (2009) Close bidirectional relationship between chronic kidney disease and atrial fibrillation: the Niigata preventive medicine study. Am Heart J 158:629–636PubMedCrossRef

26.

Manjunath G, Tighouart H, Hibrahim H et al (2003) Level of kidney function as a risk factor for cardiovascular outcomes in the community. J Am Coll Cardiol 41(1):47–55PubMedCrossRef

27.

Goldenberg I, Moss AJ, Mcnitt S et al (2006) Relations among renal function, risk of sudden cardiac death and benefit of the implanted cardiac defibrillator in patients with ischemic LV dysfunction. Am J Cardiol 98:485–490PubMedCrossRef

28.

Saxon LA, Bristow MR, Bohemer J et al (2006) Predictors of sudden cardiac death and appropriate shock in the comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION). Circulation 114:2766–2772PubMedCrossRef

29.

Deo R, Lijn F, Vittinghoff E et al (2008) Kidney dysfunction and sudden cardiac death among women with coronary artery disease. Hypertension 51:1578–1582PubMedCrossRef

30.

The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators (1997) A comparison of antiarrhytmic drug therapy with ICD in patients resuscitated from near fatal ventricular arrhytmia. N Engl J Med 337:1576–1583CrossRef

31.

Hreybe H, Ezzeddine R, Bedi M et al (2006) Renal insufficiency predicts the time to first appropriate defibrillator shock. Am Heart J 151:852–856PubMedCrossRef

32.

Takahashi A, Shiga T, Shoda M et al (2009) Impact of renal dysfunction on appropriate therapy in ICD patients with non ischemic dilated cardiomyopathy. Europace 1(11):1476–1482CrossRef

33.

Cuculich PS, Sanchez JM, Kerzner R et al (2007) Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 30:207–213PubMedCrossRef

34.

Wase A, Basit A, Nazir R et al (2004) Impact of chronic kidney disease among ICD recipients. J Interv Card Electrophys 11:199–204CrossRef

35.

Amin MS, Fox AD, Kalahasty G et al (2008) Benefit of primary prevention implantable cardioverter defibrillators in the setting of chronic kidney disease: a decision model analysis. J Cardiovasc Electrophysiol 19:1275–1280PubMedCrossRef

Titel: Arrhythmic complication in cardiorenal syndrome
verfasst von: Luigi Padeletti
Lisa Innocenti
Alessandro Paoletti Perini
Edoardo Gronda
Publikationsdatum: 01.11.2011
Verlag: Springer US
Erschienen in: Heart Failure Reviews / Ausgabe 6/2011
Print ISSN: 1382-4147
Elektronische ISSN: 1573-7322
DOI: https://doi.org/10.1007/s10741-010-9210-6

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Arrhythmic complication in cardiorenal syndrome

Abstract

Neu im Fachgebiet Kardiologie

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Darf man die Behandlung eines Neonazis ablehnen?

Update Kardiologie

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2011

Current treatment in acute and chronic cardio-renal syndrome

Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels

Cardio-renal syndrome: an entity cardiologists and nephrologists should be dealing with collegially

Anemia in Cardio-Renal Syndrome: clinical impact and pathophysiologic mechanisms

Erratum to: Epidemiology and outcome of the cardio-renal syndrome

Cardio-renal syndromes: from foggy bottoms to sunny hills

Neu im Fachgebiet Kardiologie

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Darf man die Behandlung eines Neonazis ablehnen?

Update Kardiologie